Skip to main content
logo
Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
2.700
-0.080 (-2.88%)
At close: Jun 10, 2026, 4:00 PM EDT
2.868
+0.168 (6.21%)
Pre-market: Jun 11, 2026, 8:55 AM EDT

Tvardi Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---20.9741.8723.03
Revenue Growth (YoY)
----49.92%81.81%-82.95%
Cost of Revenue
---6.177.27-
Gross Profit
---14.7934.623.03
Selling, General & Admin
9.638.744.4627.7830.2629.41
Research & Development
19.8118.0123.65108.5191.8882.7
Total Operating Expenses
29.4526.7528.11136.29122.14112.11
Operating Income
-29.45-26.75-28.11-121.5-87.54-89.08
Interest Income
1.351.380.75---
Interest Expense
----0.6--
Other Non-Operating Income (Expense)
12.667.16-2.043.592.060.64
Total Non-Operating Income (Expense)
14.018.53-1.292.982.060.64
Pretax Income
-15.44-18.21-29.4-118.51-85.47-88.44
Net Income
-15.44-18.21-29.4-118.51-85.47-88.44
Net Income to Common
-15.44-18.21-29.4-118.51-85.47-88.44
Shares Outstanding (Basic)
973111
Shares Outstanding (Diluted)
983111
Shares Change (YoY)
255.29%202.35%72.72%-5.79%5.85%
EPS (Basic)
-1.59-2.46-11.42-0.91-57.36-62.64
EPS (Diluted)
-3.10-3.26-11.42-0.91-57.36-62.64
Free Cash Flow
-24.67-23.5-18.31-94.45-78.77-60.13
Free Cash Flow Per Share
-2.70-3.02-7.11-63.38-52.85-42.68
Gross Margin
---70.56%82.64%100.00%
Operating Margin
----579.43%-209.08%-386.85%
Profit Margin
----565.21%-204.16%-384.06%
FCF Margin
----450.46%-188.15%-261.10%
EBITDA
-29.35-26.65-28.01-121.24-87.29-88.84
EBITDA Margin
----578.20%-208.49%-385.77%
EBIT
-29.45-26.75-28.11-121.5-87.54-89.08
EBIT Margin
----579.43%-209.08%-386.85%
SEC Filings: 10-K · 10-Q